文献速递创伤骨科关节外科

服用氯吡格雷和/或阿司匹林的髋部骨折患者早期手术的安全性:系统综述与Meta分析

Safety of Early Surgery in Hip Fracture Patients Taking Clopidogrel and/or Aspirin: A Systematic Review and Meta-Analysis.
PubMed 文献 · J Arthroplasty · 2023-11-14

该系统综述与Meta分析纳入20项观察性研究共3077例服用氯吡格雷和/或阿司匹林的髋部骨折患者,比较早期与延迟手术及抗血小板与非抗血小板组的安全性。结果显示抗血小板组早期手术术中失血量较多,但早期手术组总体并发症发生率更低且住院时间更短;术后死亡率无显著差异。作者认为基于现有证据早期手术似乎安全,需更高质量研究明确,围手术期需关注停用氯吡格雷或双联抗血小板治疗相关心血管事件风险增加。

要点

  • 服用氯吡格雷和/或阿司匹林患者早期手术术中失血量显著多于非抗血小板组(均数差17.96,95%CI 4.37至31.55,P=0.01)。
  • 抗血小板组早期手术后总体并发症发生率低于延迟手术组(OR=0.26,95%CI 0.14至0.29,P<0.001),住院时间更短(OR=0.26,95%CI 0.14至0.29,P<0.001)。
  • 术后死亡率及其他相关指标无显著差异;作者认为早期手术似乎安全,但需更高质量研究明确,并需关注围手术期停用抗血小板治疗相关心血管事件风险增加。

核心结论

  • 基于现有证据,服用氯吡格雷和/或阿司匹林的髋部骨折患者早期手术似乎安全,但需更高质量研究明确。
  • 围手术期需关注停用氯吡格雷或氯吡格雷联合阿司匹林双联抗血小板治疗相关心血管事件风险增加。

研究设计与样本

  • 系统检索PubMed/MEDLINE、Embase、Cochrane Library和Web of Science数据库,纳入股骨颈骨折、股骨转子间骨折和股骨转子下骨折患者接受早期关节置换或内固定的研究。
  • 共纳入20项观察性研究、3077例服用氯吡格雷和/或阿司匹林的患者,按早期手术与延迟手术、氯吡格雷和/或阿司匹林与非抗血小板药物分组分析。

主要发现

  • 氯吡格雷和/或阿司匹林组早期手术术中失血量显著多于非抗血小板组(均数差17.96,95%CI 4.37至31.55,P=0.01)。
  • 氯吡格雷和/或阿司匹林组早期手术后总体并发症发生率低于延迟手术组(OR=0.26,95%CI 0.14至0.29,P<0.001)。
  • 氯吡格雷和/或阿司匹林组早期手术后住院时间短于延迟手术组(OR=0.26,95%CI 0.14至0.29,P<0.001)。
  • 术后死亡率及其他相关指标无显著差异。

临床怎么用

  • 作者认为,基于现有证据,服用氯吡格雷和/或阿司匹林的髋部骨折患者早期手术似乎安全,但需更高质量研究明确。
  • 作者指出,围手术期需关注停用氯吡格雷或氯吡格雷联合阿司匹林双联抗血小板治疗相关心血管事件风险增加。

局限性

  • 作者结论指出需更高质量研究明确早期手术的安全性。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The aim of this study was to investigate the safety of early surgery in hip fracture patients who took clopidogrel and/or aspirin. METHODS: A systematic search was conducted using databases, including PubMed/MEDLINE, Embase, Cochrane Library, and Web of Science, for studies relating to early arthroplasty or internal fixation for femoral neck fractures, intertrochanteric fractures, and subtrochanteric fractures in patients taking clopidogrel and/or aspirin. A total of 20 observational studies involving 3,077 patients were included in this meta-analysis, and analyzed in groups of early surgery versus delayed surgery, and clopidogrel and/or aspirin versus nonantiplatelet agents. RESULTS: Patients in the clopidogrel and/or aspirin group who underwent early surgery had significantly more intraoperative blood loss than those in the non-antiplatelet group (mean difference = 17.96, 95% confidence interval [CI] [4.37, 31.55], P = .01), and patients in the clopidogrel and/or aspirin group had a lower overall incidence of complications after early surgery than those in the delayed surgery group (odds ratio = 0.26, 95% CI [0.14, 0.29], P < .001) and a shorter length of hospital stay (odds ratio = 0.26, 95% CI [0.14, 0.29], P < .001). There was no significant difference in postoperative mortality and other related indicators. CONCLUSIONS: Early surgery in hip fracture patients taking clopidogrel and/or aspirin appears to be safe based on the available evidence and needs to be clarified by higher quality studies. However, the increased risk of cardiovascular events associated with discontinuation of clopidogrel or clopidogrel combined with aspirin dual antiplatelet therapy requires attention in the perioperative period.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Lu W, Yon DK, Lee SW, et al. Safety of Early Surgery in Hip Fracture Patients Taking Clopidogrel and/or Aspirin: A Systematic Review and Meta-Analysis. J Arthroplasty. 2023. PMID: 37972664. doi:10.1016/j.arth.2023.11.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。